Advertisement

Infektionskrankheiten nach Nierentransplantation

  • Rudolf Peter Wüthrich

Zusammenfassung

Trotz der guten Erfolge mit Nierentransplantation darf nicht vergessen werden, daß durch die Immunsuppression ein bedeutendes Risiko für Infektionskrank-heiten entsteht. Mehr als 2/3 aller Transplantierten leiden während des ersten Jahres an einer Infektionskrankheit. Infektionen nach Nierentransplantation erzeugen eine große Morbidität und stellen eine der wichtigsten Todesursachen dieser Patienten dar.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Balfour HH, Chace BA, Stapleton JT, Simmons RL, Fryd DS (1989) A randomized, placebo- controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 320: 1381PubMedCrossRefGoogle Scholar
  2. 2.
    Balfour HH, Welo PK, Sachs GW (1985) Cytomegalovirus vaccine trial in 400 renal transplant candidates. Transplant Proc 17: 81Google Scholar
  3. 3.
    Betts RF (1982) Cytomegalovirus infection in transplant patients. Prog Med Virol 28: 44PubMedGoogle Scholar
  4. 4.
    Check FE, Ravitz BH, Alexander LC (1987) Kidney transplantation: Infectious complications. In: Toledo-Pereyra LH (ed) Immunlogy Series, vol 32: Complications of organ transplantation. Dekker, New York, pp 101–124Google Scholar
  5. 5.
    Cohen J, Hopkin J, Kurtz J (1988) Infectious complications after renal transplantation. In: Morris PJ (ed) Renal transplantation, 3rd edn, chap 23. Saunders, Philadelphia, pp 533–573Google Scholar
  6. 6.
    Grundmann R, Wienand P, Runde A, Baldamus CA, Arns W, Burkhardt U (1987) CMV-Hy- perimmunoglobulinprophylaxe nach Nierentransplantation. Dtsch Med Wschr 112: 827PubMedCrossRefGoogle Scholar
  7. 7.
    Hanto DW, Gajl-Peczalska KJ, Frizzera G, Arthur DC, Balfour HH, McClain K, Simmons RL, Najarian JS (1983) Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg 198: 356Google Scholar
  8. 8.
    Harbison MA, De Girolami PC, Jenkins RL, Hammer SM (1988) Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients. Transplantation 46: 82PubMedCrossRefGoogle Scholar
  9. 9.
    Herrera GA, Alexander RW, Cooley CF, Luke RG, Kelly DR, Curtis JJ, Gockerman JP (1985) Cytomegalovirus glomerulopathy: a controversial lesion. Kidney Int. 29: 725CrossRefGoogle Scholar
  10. 10.
    Kasiske BL, Heim-Duthoy KL, Tortorice KL, Ney AL, Ödland MD, Rao KV (1989) Polyvalent immune globulin and cytomegalovirus infection after renal transplantation. Arch Int Med 149: 2733Google Scholar
  11. 11.
    Koretz SH, Bühles WC, Brewin A (1986) (Collaborative DHPG treatment study group): Treatment of serious cytomegalovirus infections with 9-(l,3-dihydroxy-2-propoxyme- thyl)guanine in patients with AIDS and other immunodeficiencies. N Engl J Med 314: 801Google Scholar
  12. 12.
    Neumann-Haefelin D (1986) Cytomegalovirus-Infektion. Dtsch Med Wschr 111: 1251PubMedCrossRefGoogle Scholar
  13. 13.
    Peterson PK, Anderson RC (1986) Infection in renal transplant recipients. Current approaches to diagnosis, therapy, and prevention. Am J Med 81 (suppl. 1A): 2PubMedCrossRefGoogle Scholar
  14. 14.
    Plotkin SA, Smiley ML, Friedman HM, Starr SE, Fleisher GR, Wlodaver C, Dafoe DC, Friedman AD, Grossman RA, Barker CF (1984) Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants. Lancet 1: 528PubMedCrossRefGoogle Scholar
  15. 15.
    Richardson WP, Colvin RB, Cheeseman SH, Tolkoff-Rubin NE, Herrin JT, Cosimi AB, Collins AB, Hirsch MS, McClusky RT, Russell PS, Rubin RH (1981) Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med 305: 57PubMedCrossRefGoogle Scholar
  16. 16.
    Rubin RH (1993) Infectious disease complications of renal transplantation. Kidney Int 44: 221PubMedCrossRefGoogle Scholar
  17. 17.
    Rubin RH, Wolfson JS, Cosimi AB, Tolkoff-Rubin NE (1981) Infection in the renal transplant recipient. Am J Med 70: 405PubMedCrossRefGoogle Scholar
  18. 18.
    Snydman DR, Werner BG, Heinze-Lacey B et al. (1987) Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal transplant recipients. N Engl J Med 317: 1049PubMedCrossRefGoogle Scholar
  19. 19.
    Steinmuller DR, Novick AC, Streem SB, Graneto D, Swift C (1990) Intravenous immunoglobulin infusions for the prophylaxis of secondary cytomegalovirus infection. Transplantation 49: 68PubMedCrossRefGoogle Scholar
  20. 20.
    Von Willebrand E, Pettersson E, Ahonen J, Häyry P (1986) CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 42: 364CrossRefGoogle Scholar
  21. 21.
    Ziegenhagen DJ (1990) Zytomegalievirusinfektion nach Nierentransplantation. Der aktuelle Erkenntnisstand. Med Klin 85: 32Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • Rudolf Peter Wüthrich
    • 1
  1. 1.Departement für innere Medizin Abt. für NephrologieUniversitätsspital ZürichZürichSwitzerland

Personalised recommendations